Published in Proc Natl Acad Sci U S A on January 21, 2005
Nociceptors are interleukin-1beta sensors. J Neurosci (2008) 2.26
IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice. Proc Natl Acad Sci U S A (2008) 1.67
Cytokine signaling mediates UV-induced nociceptive sensitization in Drosophila larvae. Curr Biol (2009) 1.56
Peripheral mechanisms of pain and analgesia. Brain Res Rev (2008) 1.55
Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism. Ann Rheum Dis (2015) 1.49
Commensal microbiota is fundamental for the development of inflammatory pain. Proc Natl Acad Sci U S A (2008) 1.28
Mode of action of cytokines on nociceptive neurons. Exp Brain Res (2009) 1.26
The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain. Proc Natl Acad Sci U S A (2009) 1.24
A crucial role for TNF-alpha in mediating neutrophil influx induced by endogenously generated or exogenous chemokines, KC/CXCL1 and LIX/CXCL5. Br J Pharmacol (2009) 1.23
Bv8, the amphibian homologue of the mammalian prokineticins, induces a proinflammatory phenotype of mouse macrophages. Br J Pharmacol (2006) 1.19
The role of enhanced cutaneous IL-1beta signaling in a rat tibia fracture model of complex regional pain syndrome. Pain (2009) 1.15
GRK2: a novel cell-specific regulator of severity and duration of inflammatory pain. J Neurosci (2010) 1.15
Pentoxifylline attenuates nociceptive sensitization and cytokine expression in a tibia fracture rat model of complex regional pain syndrome. Eur J Pain (2008) 1.13
TNF signaling contributes to the development of nociceptive sensitization in a tibia fracture model of complex regional pain syndrome type I. Pain (2007) 1.11
Chemokine contribution to neuropathic pain: respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons. Pain (2013) 1.10
Up-regulation of dorsal root ganglia BDNF and trkB receptor in inflammatory pain: an in vivo and in vitro study. J Neuroinflammation (2011) 1.10
A p38 mitogen-activated protein kinase-dependent mechanism of disinhibition in spinal synaptic transmission induced by tumor necrosis factor-alpha. J Neurosci (2010) 1.10
Tumor necrosis factor-α induces sensitization of meningeal nociceptors mediated via local COX and p38 MAP kinase actions. Pain (2010) 1.09
Fracture induces keratinocyte activation, proliferation, and expression of pro-nociceptive inflammatory mediators. Pain (2010) 1.09
Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection. Proc Natl Acad Sci U S A (2009) 1.08
Role of substance P signaling in enhanced nociceptive sensitization and local cytokine production after incision. Pain (2009) 1.07
Relevance of tumour necrosis factor-alpha for the inflammatory and nociceptive responses evoked by carrageenan in the mouse paw. Br J Pharmacol (2006) 1.03
Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy. Cytokine (2012) 1.03
Genetic and nongenetic covariates of pain severity in patients with adenocarcinoma of the pancreas: assessing the influence of cytokine genes. J Pain Symptom Manage (2009) 1.02
Minocycline blocks lipopolysaccharide induced hyperalgesia by suppression of microglia but not astrocytes. Neuroscience (2012) 1.01
The α7 nicotinic ACh receptor agonist compound B and positive allosteric modulator PNU-120596 both alleviate inflammatory hyperalgesia and cytokine release in the rat. Br J Pharmacol (2012) 0.98
Carvacrol attenuates mechanical hypernociception and inflammatory response. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.98
Treatment with DF 2162, a non-competitive allosteric inhibitor of CXCR1/2, diminishes neutrophil influx and inflammatory hypernociception in mice. Br J Pharmacol (2008) 0.98
The influence of tumor necrosis factor-alpha -308 G/A and IL-6 -174 G/C on pain and analgesia response in lung cancer patients receiving supportive care. Cancer Epidemiol Biomarkers Prev (2008) 0.96
Atorvastatin inhibits inflammatory hypernociception. Br J Pharmacol (2006) 0.96
Role of inflammation gene polymorphisms on pain severity in lung cancer patients. Cancer Epidemiol Biomarkers Prev (2009) 0.95
Fractalkine mediates inflammatory pain through activation of satellite glial cells. Proc Natl Acad Sci U S A (2013) 0.94
Metalloproteinase MT5-MMP is an essential modulator of neuro-immune interactions in thermal pain stimulation. Proc Natl Acad Sci U S A (2009) 0.94
Suppression of carrageenan- and collagen II-induced inflammation in mice by geranium oil. Mediators Inflamm (2006) 0.93
Cot/tpl2 (MAP3K8) mediates myeloperoxidase activity and hypernociception following peripheral inflammation. J Biol Chem (2010) 0.93
IL-33/ST2 signalling contributes to carrageenin-induced innate inflammation and inflammatory pain: role of cytokines, endothelin-1 and prostaglandin E2. Br J Pharmacol (2013) 0.91
Hyperbaric oxygen therapy ameliorates TNBS-induced acute distal colitis in rats. Med Gas Res (2015) 0.91
Lipopolysaccharide induces inflammatory hyperalgesia triggering a TLR4/MyD88-dependent cytokine cascade in the mice paw. PLoS One (2014) 0.90
Role of complement C5a in mechanical inflammatory hypernociception: potential use of C5a receptor antagonists to control inflammatory pain. Br J Pharmacol (2007) 0.90
Stress-induced allodynia--evidence of increased pain sensitivity in healthy humans and patients with chronic pain after experimentally induced psychosocial stress. PLoS One (2013) 0.90
IL-15 mediates immune inflammatory hypernociception by triggering a sequential release of IFN-gamma, endothelin, and prostaglandin. Proc Natl Acad Sci U S A (2006) 0.89
Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists. J Bone Miner Res (2013) 0.89
Enhancement by interleukin-1β of AMPA and NMDA receptor-mediated currents in adult rat spinal superficial dorsal horn neurons. Mol Pain (2013) 0.88
Lectin extracted from Canavalia grandiflora seeds presents potential anti-inflammatory and analgesic effects. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.88
Kinin B2 receptor regulates chemokines CCL2 and CCL5 expression and modulates leukocyte recruitment and pathology in experimental autoimmune encephalomyelitis (EAE) in mice. J Neuroinflammation (2008) 0.87
Antihypernociceptive activity of anethole in experimental inflammatory pain. Inflammopharmacology (2012) 0.86
Bioactive Fraction of Geopropolis from Melipona scutellaris Decreases Neutrophils Migration in the Inflammatory Process: Involvement of Nitric Oxide Pathway. Evid Based Complement Alternat Med (2013) 0.86
Evidence of different mediators of central inflammation in dysfunctional and inflammatory pain--interleukin-8 in fibromyalgia and interleukin-1 β in rheumatoid arthritis. J Neuroimmunol (2015) 0.85
NOSH-aspirin (NBS-1120), a dual nitric oxide and hydrogen sulfide-releasing hybrid, reduces inflammatory pain. Pharmacol Res Perspect (2015) 0.85
Anti-Inflammatory and Antihyperalgesic Activities of Ethanolic Extract and Fruticulin A from Salvia lachnostachys Leaves in Mice. Evid Based Complement Alternat Med (2014) 0.85
Cooperative role of tumour necrosis factor-α, interleukin-1β and neutrophils in a novel behavioural model that concomitantly demonstrates articular inflammation and hypernociception in mice. Br J Pharmacol (2011) 0.85
Benefits of exercise intervention in reducing neuropathic pain. Front Cell Neurosci (2014) 0.85
Acute inhibition of signalling phenotype of spinal GABAergic neurons by tumour necrosis factor-alpha. J Physiol (2011) 0.85
Antinociceptive and anti-inflammatory effects of a mucin-binding agglutinin isolated from the red marine alga Hypnea cervicornis. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.85
Caspase-1 is involved in the genesis of inflammatory hypernociception by contributing to peripheral IL-1β maturation. Mol Pain (2010) 0.83
The connection of monocytes and reactive oxygen species in pain. PLoS One (2013) 0.83
Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice. Naunyn Schmiedebergs Arch Pharmacol (2015) 0.82
Targeting the minor pocket of C5aR for the rational design of an oral allosteric inhibitor for inflammatory and neuropathic pain relief. Proc Natl Acad Sci U S A (2014) 0.82
A Multiplex Protein Panel Applied to Cerebrospinal Fluid Reveals Three New Biomarker Candidates in ALS but None in Neuropathic Pain Patients. PLoS One (2016) 0.82
Analgesic activity of the ethanolic extract of Shorea robusta resin in experimental animals. Indian J Pharmacol (2012) 0.81
β2- and β3-adrenergic receptors drive COMT-dependent pain by increasing production of nitric oxide and cytokines. Pain (2014) 0.81
LASSBio-1135: a dual TRPV1 antagonist and anti-TNF-alpha compound orally effective in models of inflammatory and neuropathic pain. PLoS One (2014) 0.81
Associations between cytokine gene variations and severe persistent breast pain in women following breast cancer surgery. J Pain (2013) 0.80
Anti-nociceptive and anti-inflammatory activities of (-)-α-bisabolol in rodents. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.80
Bosentan, an endothelin receptor antagonist, ameliorates collagen-induced arthritis: the role of TNF-α in the induction of endothelin system genes. Inflamm Res (2012) 0.80
Two sides of the same coin no longer: genetic separation of nociceptive sensitization responses. Commun Integr Biol (2009) 0.80
Celastrol attenuates inflammatory and neuropathic pain mediated by cannabinoid receptor type 2. Int J Mol Sci (2014) 0.80
Anti-inflammatory and anti-hyperalgesic effect of all-trans retinoic acid in carrageenan-induced paw edema in Wistar rats: involvement of peroxisome proliferator-activated receptor-β/δ receptors. Indian J Pharmacol (2013) 0.80
The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting. Nat Rev Immunol (2016) 0.80
Modulation of Voltage-Gated Sodium Channels by Activation of Tumor Necrosis Factor Receptor-1 and Receptor-2 in Small DRG Neurons of Rats. Mediators Inflamm (2015) 0.79
Fructose-1,6-bisphosphate reduces inflammatory pain-like behaviour in mice: role of adenosine acting on A1 receptors. Br J Pharmacol (2009) 0.79
Effects of NSAIDs and paracetamol (acetaminophen) on protein kinase C epsilon translocation and on substance P synthesis and release in cultured sensory neurons. J Pain Res (2013) 0.79
Antinociceptive activity of the ethanolic extract, fractions, and aggregatin D isolated from Sinningia aggregata tubers. PLoS One (2015) 0.79
Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis. Nat Rev Rheumatol (2016) 0.79
Inhibition of the Rho/Rho kinase pathway prevents lipopolysaccharide-induced hyperalgesia and the release of TNF-α and IL-1β in the mouse spinal cord. Sci Rep (2015) 0.78
Nimesulide inhibits protein kinase C epsilon and substance P in sensory neurons - comparison with paracetamol. J Pain Res (2011) 0.78
Opioids enhance CXCL1 expression and function after incision in mice. J Pain (2014) 0.78
Anti-inflammatory activity of Choisya ternata Kunth essential oil, ternanthranin, and its two synthetic analogs (methyl and propyl N-methylanthranilates). PLoS One (2015) 0.78
Tissue injury and related mediators of pain exacerbation. Curr Neuropharmacol (2013) 0.78
A study of the mechanisms underlying the anti-inflammatory effect of ellagic acid in carrageenan-induced paw edema in rats. Indian J Pharmacol (2015) 0.78
TNF-alpha neutralizing antibody blocks thermal sensitivity induced by compound 48/80-provoked mast cell degranulation. F1000Res (2013) 0.77
Joint production of IL-22 participates in the initial phase of antigen-induced arthritis through IL-1β production. Arthritis Res Ther (2015) 0.77
Morphine enhances IL-1β release through toll-like receptor 4-mediated endocytic pathway in microglia. Purinergic Signal (2016) 0.77
Gastroprotective activity of carvacrol on experimentally induced gastric lesions in rodents. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.77
Skin matters! The role of keratinocytes in nociception: a rational argument for the development of topical analgesics. J Pain Res (2016) 0.77
Aleurites moluccana (L.) Willd. Leaves: Mechanical Antinociceptive Properties of a Standardized Dried Extract and Its Chemical Markers. Evid Based Complement Alternat Med (2011) 0.77
Effect of estragole on leukocyte behavior and phagocytic activity of macrophages. Evid Based Complement Alternat Med (2014) 0.77
Riparin B, a Synthetic Compound Analogue of Riparin, Inhibits the Systemic Inflammatory Response and Oxidative Stress in Mice. Inflammation (2015) 0.77
The ruthenium nitric oxide donor, [Ru(HEDTA)NO], inhibits acute nociception in mice by modulating oxidative stress, cytokine production and activating the cGMP/PKG/ATP-sensitive potassium channel signaling pathway. Naunyn Schmiedebergs Arch Pharmacol (2014) 0.76
Vinpocetine reduces carrageenan-induced inflammatory hyperalgesia in mice by inhibiting oxidative stress, cytokine production and NF-κB activation in the paw and spinal cord. PLoS One (2015) 0.76
The inflammasome as a target for pain therapy. Br J Anaesth (2016) 0.76
Atenolol Reduces Leishmania major-Induced Hyperalgesia and TNF-α Without Affecting IL-1β or Keratinocyte Derived Chemokines (KC). Front Pharmacol (2016) 0.76
Contribution of α,β-Amyrenone to the Anti-Inflammatory and Antihypersensitivity Effects of Aleurites moluccana (L.) Willd. Biomed Res Int (2014) 0.75
The anti-inflammatory and immunomodulatory potential of braylin: Pharmacological properties and mechanisms by in silico, in vitro and in vivo approaches. PLoS One (2017) 0.75
Participation of the NO/cGMP/K+ATP pathway in the antinociception induced by Walker tumor bearing in rats. Braz J Med Biol Res (2012) 0.75
Drosophila caspase activity is required independently of apoptosis to produce active TNF/Eiger during nociceptive sensitization. Cell Death Dis (2017) 0.75
Neuronal Subtype and Satellite Cell Tropism Are Determinants of Varicella-Zoster Virus Virulence in Human Dorsal Root Ganglia Xenografts In Vivo. PLoS Pathog (2015) 0.75
The snake venom metalloproteinase BaP1 induces joint hypernociception through TNF-alpha and PGE2-dependent mechanisms. Br J Pharmacol (2007) 0.75
Neovestitol, an isoflavonoid isolated from Brazilian red propolis, reduces acute and chronic inflammation: involvement of nitric oxide and IL-6. Sci Rep (2016) 0.75
Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. Adv Immunol (1994) 11.21
Molecular mechanisms of nociception. Nature (2001) 7.75
Proinflammatory cytokines. Chest (2000) 5.89
Animal models of nociception. Pharmacol Rev (2001) 5.76
The induction of pain: an integrative review. Prog Neurobiol (1999) 3.70
The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol (1992) 3.21
Preserved acute pain and reduced neuropathic pain in mice lacking PKCgamma. Science (1997) 2.98
Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett (2004) 2.97
Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors. Proc Natl Acad Sci U S A (1996) 2.84
Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol (1997) 2.59
Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. Eur J Pharmacol (2000) 2.16
Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol (1995) 2.12
Sepsis and cytokines: current status. Br J Anaesth (1996) 1.96
Epinephrine produces a beta-adrenergic receptor-mediated mechanical hyperalgesia and in vitro sensitization of rat nociceptors. J Neurophysiol (1999) 1.92
Characterization of cytokine-induced hyperalgesia. Brain Res (1994) 1.78
Cytokines and fever. Front Biosci (2004) 1.78
The hyperalgesic effects of prostacyclin and prostaglandin E2. Prostaglandins (1978) 1.74
The murine interleukin 8 type B receptor homologue and its ligands. Expression and biological characterization. J Biol Chem (1994) 1.72
Interleukin-8 as a mediator of sympathetic pain. Br J Pharmacol (1991) 1.71
The neutrophil chemoattractant produced by the rat kidney epithelioid cell line NRK-52E is a protein related to the KC/gro protein. J Biol Chem (1989) 1.68
Mediation of primary afferent peripheral hyperalgesia by the cAMP second messenger system. Neuroscience (1989) 1.62
An electronic pressure-meter nociception paw test for mice. Braz J Med Biol Res (2004) 1.56
Hyperalgesia in experimental neuropathy is dependent on the TNF receptor 1. Exp Neurol (1998) 1.53
A peripheral sympathetic component in inflammatory hyperalgesia. Eur J Pharmacol (1987) 1.53
I - Prostaglandin hyperalgesia, a cAMP/Ca2+ dependent process. Prostaglandins (1979) 1.52
The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis. Br J Rheumatol (1995) 1.49
Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br J Pharmacol (1993) 1.44
Prostaglandins facilitate peptide release from rat sensory neurons by activating the adenosine 3',5'-cyclic monophosphate transduction cascade. J Neurosci (1995) 1.34
Mechanisms of tumor necrosis factor-alpha (TNF-alpha) hyperalgesia. Brain Res (1995) 1.25
Intradermal injection of norepinephrine evokes pain in patients with sympathetically maintained pain. Pain (2000) 1.23
Pharmacological modulation of secondary mediator systems--cyclic AMP and cyclic GMP--on inflammatory hyperalgesia. Br J Pharmacol (1999) 1.22
Role of lipocortin-1 in the anti-hyperalgesic actions of dexamethasone. Br J Pharmacol (1997) 1.15
The pathophysiological role of cytokines. Leg Med (Tokyo) (2003) 1.11
Contribution of protein kinase C to central sensitization and persistent pain following tissue injury. Neurosci Lett (1992) 1.10
Cytokine-induced neutrophil chemoattractant 1 (CINC-1) mediates the sympathetic component of inflammatory mechanical hypersensitivitiy in rats. Eur Cytokine Netw (2003) 1.07
Effects of peripheral antisympathetic treatments in the tail-flick, formalin and autotomy tests. Pain (1984) 1.06
Peripheral hyperalgesic cytokines. Adv Exp Med Biol (2003) 1.06
Analgesic effect of thalidomide on inflammatory pain. Eur J Pharmacol (2000) 1.06
Activation of presynaptic NMDA receptors coupled to NaV1.8-resistant sodium channel C-fibers causes retrograde mechanical nociceptor sensitization. Proc Natl Acad Sci U S A (2003) 1.02
Bradykinin B1 and B2 receptors, tumour necrosis factor alpha and inflammatory hyperalgesia. Br J Pharmacol (1999) 1.02
Interleukin-1 enhances pain reflexes. Mediation through increased prostaglandin E2 levels. Agents Actions (1988) 1.00
Nerve growth factor induced hyperalgesia in the rat hind paw is dependent on circulating neutrophils. Pain (1998) 1.00
The role of the sympathetic efferents in endotoxin-induced localized inflammatory hyperalgesia and cytokine upregulation. Neuropharmacology (2002) 0.97
In vivo evidence for a role of protein kinase C in peripheral nociceptive processing. Br J Pharmacol (2002) 0.96
alpha 1-adrenoceptors in normal and hyperalgesic human skin. Clin Sci (Lond) (1996) 0.92
Relief of causalgia in limbs yb regional intravenous guanethidine. Br Med J (1979) 0.87
Effects of various analgesic and anti-inflammatory drugs on endotoxin-induced hyperalgesia in rats and mice. Pharmacology (1997) 0.87
Effects of regional intravenous guanethidine in patients with neuralgia in the hand; a follow-up study over a decade. Pain (1995) 0.79
Electromotive administration of guanethidine for treatment of reflex sympathetic dystrophy: a pilot study in eight patients. J Pain Symptom Manage (1994) 0.79
Prostaglandins: their disappearance from and release into the circulation. Nature (1967) 8.66
Indomethacin and aspirin abolish prostaglandin release from the spleen. Nat New Biol (1971) 5.62
Prostaglandins, aspirin-like drugs and analgesia. Nat New Biol (1972) 4.91
Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature (2001) 4.82
Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg (1984) 3.96
The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol (1992) 3.21
Prostaglandins, aspirin-like drugs and the oedema of inflammation. Nature (1973) 3.20
Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature (1988) 2.72
Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol (1997) 2.59
Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev (1996) 2.55
The disappearance of bradykinin and eledoisin in the circulation and vascular beds of the cat. Br J Pharmacol Chemother (1967) 2.44
Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect Immun (1994) 2.35
Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infect Immun (1996) 2.18
Central and peripheral antialgesic action of aspirin-like drugs. Eur J Pharmacol (1978) 2.18
Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. Eur J Pharmacol (2000) 2.16
Sequence and expression of the discoidin I gene family in Dictyostelium discoideum. J Mol Biol (1981) 2.16
Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol (1995) 2.12
Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs. Br J Pharmacol (1973) 2.07
Identification of a novel gene cluster encoding staphylococcal exotoxin-like proteins: characterization of the prototypic gene and its protein product, SET1. Infect Immun (2000) 2.07
Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect Immun (1995) 1.94
Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166) Arch Gen Psychiatry (1999) 1.94
Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells. Infect Immun (1996) 1.93
Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom. Biochemistry (1970) 1.86
Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology (1997) 1.86
Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major. Eur J Immunol (1994) 1.82
Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity. Circulation (2000) 1.82
Proceedings: Prostaglandin generation maintains the smooth muscle tone of the rabbit isolated jejunum. Br J Pharmacol (1972) 1.80
The detection and estimation of bradykinin in the circulating blood. Br J Pharmacol Chemother (1967) 1.80
A simple sensitive bioassay for interleukin-1 which is unresponsive to 10(3) U/ml of interleukin-2. J Immunol Methods (1987) 1.80
Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol (1993) 1.79
Circulating interleukin-6 mediates the febrile response to localised inflammation in rats. J Physiol (2000) 1.75
The hyperalgesic effects of prostacyclin and prostaglandin E2. Prostaglandins (1978) 1.74
Tool support for authoring eligibility criteria for cancer trials. Proc AMIA Symp (1999) 1.73
Interleukin-8 as a mediator of sympathetic pain. Br J Pharmacol (1991) 1.71
Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration "in vivo" by indirect mechanisms. Agents Actions (1990) 1.71
IL-10 mediates susceptibility to Trypanosoma cruzi infection. J Immunol (1994) 1.70
Participation of the sympathetic system in acetic acid-induced writhing in mice. Braz J Med Biol Res (1988) 1.66
Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease. J Dent Res (2007) 1.65
Modulation of mucosal immunity in a murine model of food-induced intestinal inflammation. Clin Exp Allergy (2007) 1.65
Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4+ effector memory T-cells. Br J Pharmacol (2010) 1.65
The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia. Mol Psychiatry (2006) 1.64
II - Prostaglandin hyperalgesia: the peripheral analgesic activity of morphine, enkephalins and opioid antagonists. Prostaglandins (1979) 1.63
Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi. Microbes Infect (2000) 1.63
Analysis of the multigene family coding the developmentally regulated carbohydrate-binding protein discoidin-I in D. discoideum. Cell (1980) 1.60
An electronic pressure-meter nociception paw test for mice. Braz J Med Biol Res (2004) 1.56
IL-8 causes in vivo neutrophil migration by a cell-dependent mechanism. Immunology (1991) 1.54
A peripheral sympathetic component in inflammatory hyperalgesia. Eur J Pharmacol (1987) 1.53
I - Prostaglandin hyperalgesia, a cAMP/Ca2+ dependent process. Prostaglandins (1979) 1.52
Some effects of inhibiting endogenous prostaglandin formation on the responses of the cat spleen. Br J Pharmacol (1973) 1.47
Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease. Oral Microbiol Immunol (2009) 1.45
Cytokine profiles during carrageenan-induced inflammatory hyperalgesia in rat muscle and hind paw. J Pain (2006) 1.45
Blockade by antimacrophage serum of the migration of PMN neutrophils into the inflamed peritoneal cavity. Agents Actions (1985) 1.45
Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br J Pharmacol (1993) 1.44
beta-Chemokines enhance parasite uptake and promote nitric oxide-dependent microbiostatic activity in murine inflammatory macrophages infected with Trypanosoma cruzi. Infect Immun (1999) 1.44
Mouse paw edema. A new model for inflammation? Braz J Med Biol Res (1987) 1.42
Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. Oral Microbiol Immunol (2006) 1.40
An electronic pressure-meter nociception paw test for rats. Braz J Med Biol Res (2004) 1.39
The role of parasite persistence in pathogenesis of Chagas heart disease. Parasite Immunol (2009) 1.39
The effects of antiinflammatory drugs on the production of prostaglandins in vivo. Adv Prostaglandin Thromboxane Res (1976) 1.36
An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine. Eur J Neurosci (2005) 1.36
Modulation of chemokine production and inflammatory responses in interferon-gamma- and tumor necrosis factor-R1-deficient mice during Trypanosoma cruzi infection. Am J Pathol (2001) 1.36
Inhibition of prostaglandin biosynthesis as the mechanism of analgesia of aspirin-like drugs in the dog knee joint. Eur J Pharmacol (1975) 1.34
Mycobacterium tuberculosis chaperonin 60.1 is a more potent cytokine stimulator than chaperonin 60.2 (Hsp 65) and contains a CD14-binding domain. Infect Immun (2001) 1.33
Lipopolysaccharide induces sickness behaviour in rats by a vagal mediated mechanism. C R Acad Sci III (1994) 1.33
The dual role of p55 tumour necrosis factor-alpha receptor in Actinobacillus actinomycetemcomitans-induced experimental periodontitis: host protection and tissue destruction. Clin Exp Immunol (2007) 1.32
Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Eur J Pharmacol (1990) 1.32
Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusion injury. Br J Pharmacol (2001) 1.30
Role of nitric oxide in the failure of neutrophil migration in sepsis. J Infect Dis (2000) 1.30
The major role of peripheral release of histamine and 5-hydroxytryptamine in formalin-induced nociception. Neuroscience (2001) 1.30
The effect of photodynamic action on two virulence factors of gram-negative bacteria. Photochem Photobiol (2000) 1.30
A laminar flow superfusion technique with much increased sensitivity for the detection of smooth muscle-stimulating substances. Eur J Pharmacol (1976) 1.29
Prostaglandin production by rabbit isolated jejunum and its relationship to the inherent tone of the preparation. Br J Pharmacol (1976) 1.29
Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in inflammation. J Neurosci (1996) 1.28
Commensal microbiota is fundamental for the development of inflammatory pain. Proc Natl Acad Sci U S A (2008) 1.28
Activity of various fractions of bradykinin potentiating factor against angiotensin I converting enzyme. Nature (1970) 1.27
Half-lives of peptides and amines in the circulation. Nature (1967) 1.27
Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity. Drug Alcohol Depend (2001) 1.27
Homogeneous Escherichia coli chaperonin 60 induces IL-1 beta and IL-6 gene expression in human monocytes by a mechanism independent of protein conformation. J Immunol (1998) 1.27
Interferon-gamma and tumor necrosis factor-alpha determine resistance to Paracoccidioides brasiliensis infection in mice. Am J Pathol (2000) 1.26